日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase II Study of Pegvorhyaluronidase Alfa (PEGPH20) and Pembrolizumab for Patients with Hyaluronan-High, Pretreated Metastatic Pancreatic Ductal Adenocarcinoma: PCRT16-001

聚乙二醇化透明质酸酶α (PEGPH20) 联合帕博利珠单抗治疗透明质酸高表达、既往接受过治疗的转移性胰腺导管腺癌患者的 II 期研究:PCRT16-001

Chiorean, Elena Gabriela; Damle, Sheela R; Zhen, David B; Whittle, Martin; George, Ben; Hochster, Howard; Coveler, Andrew L; Hendifar, Andrew; Dragovich, Tomislav; Safyan, Rachael A; King, Gentry T; Harris, William P; Dion, Barbara; Stoll D'Astice, Amy; Lee, Arthur; Thorsen, Shelley; Kugel, Sita; Rosenthal, Adam; Hingorani, Sunil

Phase 2 study of azacitidine plus pembrolizumab as second-line treatment in patients with locally advanced or metastatic pancreatic ductal adenocarcinoma

阿扎胞苷联合帕博利珠单抗作为局部晚期或转移性胰腺导管腺癌患者二线治疗的II期研究

Safyan, Rachael A; White, Ruth A; Gonda, Tamas A; Lee, Shing M; Han, Jiying; Kuriakose, Nadine; Yamamoto, Naomi K; Kugel, Sita; Jamison, Jacob K; Manji, Gulam A; Schwartz, Gary J; Oberstein, Paul E; Bates, Susan E

Innovative Aboodh-based gractional analytical methods for nonlinear Burgers' partial differential equations

基于 Aboodh 的非线性 Burgers 偏微分方程的创新性分数解析方法

Iqbal, Naveed; Aldhabani, Musaad S; Haleemzai, Izatmand; Zaidi, Hasan Nihal; Hussain, Shah; Mukhtar, Safyan; Mohammed, Wael W

HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal Adenocarcinoma

HMGA2表达可预测胰腺导管腺癌的亚型、生存期和治疗结果

Naomi Yamamoto ,Stephanie Dobersch ,Ian Loveless ,Annie N Samraj ,Gun Ho Jang ,Miki Haraguchi ,Liang-I Kang ,Marianna B Ruzinova ,Kiran R Vij ,Jacqueline L Mudd ,Thomas Walsh ,Rachael A Safyan ,Elena Gabriela Chiorean ,Sunil R Hingorani ,Nathan M Bolton ,Li Li ,Ryan C Fields ,David G DeNardo ,Faiyaz Notta ,Howard C Crawford ,Nina G Steele ,Sita Kugel

Phase Ia/Ib Study of Afatinib with Capecitabine in Patients with Refractory Solid Tumors and Pancreaticobiliary Cancers

阿法替尼联合卡培他滨治疗难治性实体瘤和胰胆管癌患者的Ia/Ib期研究

King, Gentry G; Baker, Kelsey K; Coveler, Andrew L; Harris, William P; Cohen, Stacey A; Shankaran, Veena; Zhen, David B; Safyan, Rachael A; Lee, Hannah H; Alidina, Annie; Hensel, Jeniece; Hibbert, Reina; Durm, Greg A; LaFary, Yvonne C; Younger, Anne; Kugel, Sita; Collisson, Eric; Konnick, Eric Q; Redman, Mary W; Schneider, Bryan P; Pritchard, Colin C; Shahda, Safi; Chiorean, Elena Gabriela

Long-Term Survival Following Chemoradiation in Locoregional Recurrent Germline ATM Mutated Pancreatic Ductal Adenocarcinoma

局部复发性生殖系ATM突变胰腺导管腺癌患者接受放化疗后的长期生存率

Safyan, Rachael A; Zhang, Keven; Apisarnthanarax, Smith; Sham, Jonathan G; Pillarisetty, Venu G; Kugel, Sita; Dubard-Gault, Marianne; Pritchard, Colin C; Konnick, Eric Q; Sahani, Dushyant; Chiorean, E Gabriela

S2303: phase II/III trial of paclitaxel + ramucirumab ± nivolumab in gastric and esophageal adenocarcinoma (PARAMUNE)

S2303:紫杉醇+雷莫芦单抗±纳武利尤单抗治疗胃癌和食管腺癌的II/III期试验(PARAMUNE)

Saeed, Anwaar; Colby, Sarah; Oberstein, Paul Eliezer; Duda, Dan G; Park, Robin; Agarwal, Rajiv; Figueroa-Moseley, Colmar; Vaidya, Riha; Unger, Joseph M; Guthrie, Katherine A; Rocha, Flavio G; Senthil, Maheswari; Safyan, Rachael A; Wainberg, Zev A; Iqbal, Syma; Chiorean, E Gabriela; Philip, Philip A

A new dawn in cancer immunotherapy: the promise of mutant KRAS-specific vaccines

癌症免疫疗法的新曙光:突变型KRAS特异性疫苗的希望

Damle, Sheela Ruby; Pillarisetty, Venu Gopal; Safyan, Rachael Ann; Chiorean, Elena Gabriela

Dally is not essential for Dpp spreading or internalization but for Dpp stability by antagonizing Tkv-mediated Dpp internalization

Dally 对 Dpp 扩散或内化并非至关重要,但通过拮抗 Tkv 介导的 Dpp 内化,对 Dpp 稳定性至关重要

Niklas Simon #, Abu Safyan #, George Pyrowolakis, Shinya Matsuda

A genome-engineered tool set for Drosophila TGF-β/BMP signaling studies

用于果蝇 TGF-β/BMP 信号研究的基因组工程工具集

Clara-Maria Ell, Abu Safyan, Mrinal Chayengia, Manuela M M Kustermann, Jennifer Lorenz, Melanie Schächtle, George Pyrowolakis